23 Industry Brief The growing prevalence of different types of head and neck cancers is expected to drive the growth of Global Head and Neck Ca nce r Therapeutics through 2027. According to TechSci report on, “Global Head and Neck Cancer Therapeutics Market - By Region, Competition Forecast & Opportunities, 2027 ” . Global Head and Neck Cancer Therapeutics Market stood at USD 2024 . 33 million in 2021 and is expected to grow at an impressive rate of 7 . 22 % during the forecast period . This can be ascribed to the growth in research and development activities related to cancer treatment and developing new treatment options . The rising incidence of various types of cancer has led to an increase in demand for developing therapies and drugs to treat them . This, in turn, has made many government agencies, academic & research institutions, and biotechnology & pharmaceutical companies focus on a new therapy or drug development . These organizations are increasing their research & development activities related to cancer diagnostics and therapeutics . However, there are a lot of complications and post - surgery risks associated with various head and neck cancer surgeries . These risks or complications include temporary or permanent loss of voice, hearing loss is also observed in certain cases, faulty speech, among others . Also, there are a lot of side effects associated with chemotherapy, including harm caused to the healthy cells and cancerous cells, loss of appetite, nausea, pain, vomiting, hair loss, tiredness, anemia, sleep problems, and others . Global Head and Neck Cancer Therapeutics Market is segmented by type, by diagnostic methods, by treatment type, by disease indication, by route of administration, by therapeutic class, by end user, by region and company . Based on type, the global head and neck cancer therapeutics market can be split into diagnostic methods and treatment types . Diagnostic methods dominated the market with a share of around 56 . 89 % since Diagnostic methods form an integral part of the development of a treatment or therapy . Hence, accurate and precise diagnosis is required for developing the right treatment . Diagnostic Methods such as Biopsy, Imaging, and Endoscopy not only help in the early diagnosis and detection of cancer but are done during the treatment also in order to identify the cancer progression stages or whether the treatment provided is helping in the treatment and elimination of different types of head and neck cancer . Based on disease indication, the market can be fragmented into Lip and Oral Cavity Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Nasopharyngeal Cancer, Salivary Gland Cancer and Hypopharyngeal Cancer . The Lip and Oral Cavity Cancer is expected to dominate the market through 2027 on account of the growing prevalence of this cancer type . According to Globocan , 377 , 713 new cases of lip and oral cavity cancer were reported in 2020 and along with this number of reported deaths caused due to lip and oral cancer were around 177 , 757 . A partial list of leading companies in the Global Head and Neck Cancer Therapeutics Market includes Eli Lilly and Company , Bristol Myers Squibb Company, Sanofi S . A . , Merck & Co . , Inc . , Pfizer Inc, AbbVie Inc . , Bayer AG, F . Hoffmann - La Roche Ltd . , Fresenius Medical Care AG & Co . KGaA , Sun Pharmaceutical Industries Ltd . , Teva Pharmaceutical Industries Limited, AstraZeneca Plc . , Astellas Pharma Inc . , AB Science SA, Boston Biomedical, Inc . The Asia Pacific region is expected to register the fastest growth during the forecast period . This can be attributed to the growing prevalence of different types of head and neck cancers in the region, especially in two of the world’s highly populated countries, China and India . Additionally, extensive research & development activities, ongoing clinical trials, increasing investments, expansion of companies along with their manufacturing sites in the region especially in countries like China, Japan, Singapore, among others for the development of therapies and drugs for the treatment of different types of head and neck cancers is further expected to support the market growth in the region . ” said Mr . Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm .